Quantum BioPharma Ltd.
QNTM • Biotechnology
$3.24
▲ +0.29 (+9.83%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$14.55M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.27Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:06 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.24
Change9.83%
Shares Out4.49M
Market Cap$14.55M
Enterprise Value$5.35M
52W Range2.07 - 22.57
Beta0.44
P/E-0.47
P/B24.36
P/FCF-2.59
EV/EBITDA-0.26
EV/FCF-0.95
Price$3.24
Change9.83%
Shares Out4.49M
Market Cap$14.55M
Enterprise Value$5.35M
52W Range2.07 - 22.57
Beta0.44
P/E-0.47
P/B24.36
P/FCF-2.59
EV/EBITDA-0.26
EV/FCF-0.95
Earnings Yield-212.92%
FCF Yield-38.65%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.27
Current Ratio1.07
Quick Ratio1.06
Volume222.49K
Avg Volume300.65K
EPS Surprise-2.57
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
74/100
Why this score▼
Manageable debt level · 0.27Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.